68 related articles for article (PubMed ID: 29297704)
41. LINC02126 is a potential diagnostic, prognostic and immunotherapeutic target for lung adenocarcinoma.
Wang J; Liu J; Hou Q; Xu M
BMC Pulm Med; 2022 Nov; 22(1):412. PubMed ID: 36357869
[TBL] [Abstract][Full Text] [Related]
42. Proteomics score: a potential biomarker for the prediction of prognosis in non-small cell lung cancer.
Peng J; Zhang J; Zou D; Gong W
Transl Cancer Res; 2019 Sep; 8(5):1904-1917. PubMed ID: 35116940
[TBL] [Abstract][Full Text] [Related]
43. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
Hu J; Wang T; Chen Q
Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
[TBL] [Abstract][Full Text] [Related]
44. Bioinformatics Analysis and Functional Verification of ADAMTS9-AS1/AS2 in Lung Adenocarcinoma.
Liu W; Luo W; Zhou P; Cheng Y; Qian L
Front Oncol; 2021; 11():681777. PubMed ID: 34395250
[TBL] [Abstract][Full Text] [Related]
45. An optimal prognostic model based on gene expression for clear cell renal cell carcinoma.
Xu D; Dang W; Wang S; Hu B; Yin L; Guan B
Oncol Lett; 2020 Sep; 20(3):2420-2434. PubMed ID: 32782559
[TBL] [Abstract][Full Text] [Related]
46. Bioinformatics Analysis to Reveal Potential Differentially Expressed Long Non-Coding RNAs and Genes Associated with Tumour Metastasis in Lung Adenocarcinoma.
Yao X; Zhang H; Tang S; Zheng X; Jiang L
Onco Targets Ther; 2020; 13():3197-3207. PubMed ID: 32368079
[TBL] [Abstract][Full Text] [Related]
47. Identification of a Sixteen-gene Prognostic Biomarker for Lung Adenocarcinoma Using a Machine Learning Method.
Ma B; Geng Y; Meng F; Yan G; Song F
J Cancer; 2020; 11(5):1288-1298. PubMed ID: 31956375
[No Abstract] [Full Text] [Related]
48. Integrative analyses of noncoding RNAs reveal the potential mechanisms augmenting tumor malignancy in lung adenocarcinoma.
Shih JH; Chen HY; Lin SC; Yeh YC; Shen R; Lang YD; Wu DC; Chen CY; Chen RH; Chou TY; Jou YS
Nucleic Acids Res; 2020 Feb; 48(3):1175-1191. PubMed ID: 31853539
[TBL] [Abstract][Full Text] [Related]
49. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
[TBL] [Abstract][Full Text] [Related]
50. LncRNA HMMR-AS1 promotes proliferation and metastasis of lung adenocarcinoma by regulating MiR-138/sirt6 axis.
Cai Y; Sheng Z; Chen Y; Wang J
Aging (Albany NY); 2019 May; 11(10):3041-3054. PubMed ID: 31128573
[TBL] [Abstract][Full Text] [Related]
51. Screening of important lncRNAs associated with the prognosis of lung adenocarcinoma, based on integrated bioinformatics analysis.
Li J; Yu X; Liu Q; Ou S; Li K; Kong Y; Liu H; Ouyang Y; Xu R
Mol Med Rep; 2019 May; 19(5):4067-4080. PubMed ID: 30896819
[TBL] [Abstract][Full Text] [Related]
52. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
[TBL] [Abstract][Full Text] [Related]
53. Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis.
Serghiou S; Kyriakopoulou A; Ioannidis JP
Mol Cancer; 2016 Jun; 15(1):50. PubMed ID: 27352941
[TBL] [Abstract][Full Text] [Related]
54. A novel prognostic signature for lung adenocarcinoma based on cuproptosis-related lncRNAs: A Review.
Di H; Zhao J; Zhu X; Zhou X; Hu Y; Wang M; Qiu Z; Zhang W; Chen X
Medicine (Baltimore); 2022 Dec; 101(49):e31924. PubMed ID: 36626411
[TBL] [Abstract][Full Text] [Related]
55. LncRNA Expression Signature in Prediction of the Prognosis of Lung Adenocarcinoma.
Li L; Feng T; Qu J; Feng N; Wang Y; Ma RN; Li X; Zheng ZJ; Yu H; Qian B
Genet Test Mol Biomarkers; 2018 Jan; 22(1):20-28. PubMed ID: 29297704
[TBL] [Abstract][Full Text] [Related]
56. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma.
Zhou M; Xu W; Yue X; Zhao H; Wang Z; Shi H; Cheng L; Sun J
Oncotarget; 2016 May; 7(20):29720-38. PubMed ID: 27105492
[TBL] [Abstract][Full Text] [Related]
57. Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.
Peng F; Wang R; Zhang Y; Zhao Z; Zhou W; Chang Z; Liang H; Zhao W; Qi L; Guo Z; Gu Y
Mol Cancer; 2017 Jun; 16(1):98. PubMed ID: 28587642
[TBL] [Abstract][Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
